Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma

por Tomida, Akimasa, Yagyu, Shigeki, Nakamura, Kayoko, Kubo, Hiroshi, Yamashima, Kumiko, Nakazawa, Yozo, Hosoi, Hajime, Iehara, Tomoko
Publicado 2021

Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma

por Kubo, Hiroshi, Yagyu, Shigeki, Nakamura, Kayoko, Yamashima, Kumiko, Tomida, Akimasa, Kikuchi, Ken, Iehara, Tomoko, Nakazawa, Yozo, Hosoi, Hajime
Publicado 2021

A lymphodepleted non‐human primate model for the assessment of acute on‐target and off‐tumor toxicity of human chimeric antigen receptor‐T cells

por Yagyu, Shigeki, Mochizuki, Hidemi, Yamashima, Kumiko, Kubo, Hiroshi, Saito, Shoji, Tanaka, Miyuki, Sakamoto, Kengo, Shimoi, Akihito, Nakazawa, Yozo
Publicado 2021